Principal Financial Group Inc Biolife Solutions Inc Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$19.19 - $26.52 $164,650 - $227,541	8,580 Added 4.71%	190,715 $4.77 Million
Q2 2024 Jul 29, 2024	SELL	$15.14 - $22.99 $137,713 - $209,117	-9,096 Reduced 4.76%	182,135 $3.9 Million
Q1 2024 Apr 29, 2024	BUY	$15.35 - $18.82 $60,248 - $73,868	3,925 Added 2.1%	191,231 $3.55 Million
Q4 2023 Feb 07, 2024	SELL	$8.99 - $16.86 $28,714 - $53,850	-3,194 Reduced 1.68%	187,306 $3.04 Million
Q3 2023 Nov 02, 2023	SELL	$10.81 - $22.96 $152,885 - $324,723	-14,143 Reduced 6.91%	190,500 $2.63 Million
Q2 2023 Aug 07, 2023	SELL	$17.19 - $24.34 $144,860 - $205,113	-8,427 Reduced 3.96%	204,643 $4.52 Million
Q1 2023 May 09, 2023	SELL	$17.67 - $26.07 $48,822 - $72,031	-2,763 Reduced 1.28%	213,070 $4.63 Million
Q4 2022 Feb 09, 2023	BUY	$16.95 - $25.07 $18,407 - $27,226	1,086 Added 0.51%	215,833 $3.93 Million
Q3 2022 Nov 09, 2022	BUY	$14.64 - $26.7 $312,549 - $570,018	21,349 Added 11.04%	214,747 $4.89 Million
Q2 2022 Aug 10, 2022	SELL	$10.54 - $24.2 $95,007 - $218,138	-9,014 Reduced 4.45%	193,398 $2.67 Million
Q1 2022 May 09, 2022	BUY	$20.81 - $37.29 $50,589 - $90,651	2,431 Added 1.22%	202,412 $4.6 Million
Q4 2021 Feb 09, 2022	SELL	$32.99 - $58.55 $1 Million - $1.78 Million	-30,424 Reduced 13.2%	199,981 $7.45 Million
Q3 2021 Nov 09, 2021	BUY	$42.03 - $60.5 $9.37 Million - $13.5 Million	222,848 Added 2948.9%	230,405 $9.75 Million
Q2 2021 Aug 10, 2021	BUY	$29.51 - $44.62 $13,190 - $19,945	447 Added 6.29%	7,557 $336,000
Q1 2021 May 10, 2021	BUY	$32.95 - $44.24 $16,507 - $22,164	501 Added 7.58%	7,110 $256,000
Q4 2020 Feb 08, 2021	BUY	$27.5 - $45.75 $181,747 - $302,361	6,609 New	6,609 $264,000

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.17B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account